Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumiya Tomura

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
FASEB Bioadvances|March 4, 2020
Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe-mediated steatosis prevention and recoveryYu Toyoda, Tappei Takada, Masakazu Umezawa, et al.
Pharmaceutical Research|October 19, 2010
Human NPC1L1 expression is positively regulated by PPARαYuki Iwayanagi, Tappei Takada, Fumiya Tomura, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
FASEB Bioadvances|March 4, 2020
Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe-mediated steatosis prevention and recoveryYu Toyoda, Tappei Takada, Masakazu Umezawa, et al.
Pharmaceutical Research|October 19, 2010
Human NPC1L1 expression is positively regulated by PPARαYuki Iwayanagi, Tappei Takada, Fumiya Tomura, et al.
Pageof 1